CompletedPhase 3NCT05046951
Official study title

Educating QUitline Callers About Lung Cancer Screening

Study summary

The specific aims are: 1. To evaluate the potential barriers of providing educational lung screening interventions to quitline users, the investigators will seek input from 10-20 stakeholders on the newly adapted print version of the Should I Screen website, and on our proposed Aim 2 recruitment and retention procedures. 2. To conduct a randomized intervention, comparing: 1) ShouldIScreen.com website, (WEB; N=150); vs. 2) the Should I Screen print version (PRINT; N=150). H2.1. At 1- and 4-months post-randomization, the WEB arm will have significantly higher lung screening knowledge and intention to undergo lung screening, compared to PRINT. Randomization will be stratified by age and pack-years in order to incorporate those who are recently eligible for screening, ages 50-54 and with 20-29 pack years. H2.2 The investigators will explore several potential moderators (age and e-health literacy). For example, the investigators will explore whether older vs younger participants have differential knowledge outcomes when using the PRINT vs WEB interventions. H2.3 We will explore whether mediators (prior lung screening, current primary care provider, lung cancer perceived risk) positively affects knowledge and screening intentions. 3. To evaluate reach (% of quitline users enrolled) and engagement (% who read the intervention materials) by study arm and subgroup (e.g., method of quitline access, age, e-health literacy).

Ask AI to explain this study
Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedShould I Screen website and Should I Screen print booklet

The study team can explain what participation involves.

Who it may be forPopulation at Risk

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Mar 29, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Phase 3

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Georgetown University

Study sponsor

01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Phase 3
Sponsor
Georgetown University
Interventions being studied
Behavioral: Should I Screen website; Behavioral: Should I Screen print booklet
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • enrolled in the quitline
  • 50-80 years old
  • \>20-pack year smoking history
  • never screened or \>12 months since prior screen
  • English speaking
  • able to provide meaningful consent
  • no family members in the same household enrolled in the trial Exclusion Criterion:
  • prior lung cancer

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Georgetown University Medical CenterWashington D.C., District of Columbia

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 29, 2023. Always confirm current availability with the study team.

View original record ↗